[{"id":"a47d95f8-ca1f-486b-b0b0-ed87c3ff747f","acronym":"D5760C00001","url":"https://clinicaltrials.gov/study/NCT02576548","created_at":"2021-01-18T12:29:36.336Z","updated_at":"2024-07-02T16:36:58.814Z","phase":"Phase 1/2","brief_title":"A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.","source_id_and_acronym":"NCT02576548 - D5760C00001","lead_sponsor":"MedImmune LLC","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MEDI4276"],"overall_status":"Completed","enrollment":" Enrollment 47","initiation":"Initiation: 09/23/2015","start_date":" 09/23/2015","primary_txt":" Primary completion: 05/23/2018","primary_completion_date":" 05/23/2018","study_txt":" Completion: 05/23/2018","study_completion_date":" 05/23/2018","last_update_posted":"2019-06-18"}]